Abstract
Efficient intracellular delivery is critical to the successful application of synthetic antisense oligonucleotides (ASOs) to modulate gene expression. The conjugation of cell-penetrating peptides (CPPs) to ASOs has been shown to significantly improve their intracellular delivery. It is important, however, that formation of the covalent linkage between the peptide and oligonucleotide is efficient and orthogonal, to ensure high yields and a homogeneous product. Described herein are efficient and facile methodologies for the conjugation of peptides to ASOs, and their subsequent labeling with various moieties such as fluorescent dyes for intracellular tracking studies.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Aartsma-Rus A, Krieg AM (2017) FDA approves Eteplirsen for Duchenne muscular dystrophy: the next chapter in the Eteplirsen saga. Nucleic Acids Ther 27(1):1–3. https://doi.org/10.1089/nat.2016.0657
Biogen (2016) SPINRAZA_READINESS. http://www.spinraza-hcpcom
Betts C, Saleh AF, Arzumanov AA et al (2012) Pip6-PMO, a new generation of peptide-oligonucleotide conjugates with improved cardiac exon skipping activity for DMD treatment. Mol Ther Nucleic Acids 1:e38. https://doi.org/10.1038/mtna.2012.30
Saleh AF, Arzumanov AA, Yin H et al (2011) Enhancement of exon skipping and dystrophin production by 3′-peptide conjugates of morpholino (PMO) oligonucleotides in a mdx mouse model of Duchenne muscular dystrophy. Collection symposium series. Chem Nucl Acid Comp 12:292–296
Shabanpoor F, McClorey G, Saleh AF et al (2015) Bi-specific splice-switching PMO oligonucleotides conjugated via a single peptide active in a mouse model of Duchenne muscular dystrophy. Nucleic Acids Res 43(1):29–39. https://doi.org/10.1093/nar/gku1256
Hammond SM, Hazell G, Shabanpoor F et al (2016) Systemic peptide-mediated oligonucleotide therapy improves long-term survival in spinal muscular atrophy. Proc Natl Acad Sci U S A 113(39):10962–10967. https://doi.org/10.1073/pnas.1605731113
Yin H, Saleh AF, Betts C et al (2011) Pip5 transduction peptides direct high efficiency oligonucleotide-mediated dystrophin exon skipping in heart and phenotypic correction in mdx mice. Mol Ther 19(7):1295–1303. https://doi.org/10.1038/mt.2011.79
Boisguerin P, Deshayes S, Gait MJ et al (2015) Delivery of therapeutic oligonucleotides with cell penetrating peptides. Adv Drug Deliv Rev 87:52–67. https://doi.org/10.1016/j.addr.2015.02.008
Boisguerin P, O'Donovan L, Gait MJ et al (2015) In vitro assays to assess exon skipping in Duchenne muscular dystrophy. Methods Mol Biol 1324:317–329. https://doi.org/10.1007/978-1-4939-2806-4_20
Lehto T, Ezzat K, Wood MJ et al (2016) Peptides for nucleic acid delivery. Adv Drug Deliv Rev 106(Pt A):172–182. https://doi.org/10.1016/j.addr.2016.06.008
Shabanpoor F, Hammond SM, Abendroth F et al (2017) Identification of a peptide for systemic brain delivery of a Morpholino oligonucleotide in mouse models of spinal muscular atrophy. Nucleic Acids Ther 27(3):130–143. https://doi.org/10.1089/nat.2016.0652
Shabanpoor F, Gait MJ (2013) Development of a general methodology for labelling peptide-morpholino oligonucleotide conjugates using alkyne-azide click chemistry. Chem Commun (Camb) 49(87):10260–10262. https://doi.org/10.1039/c3cc46067c
Said Hassane F, Saleh AF, Abes R et al (2010) Cell penetrating peptides: overview and applications to the delivery of oligonucleotides. Cell Mol Life Sci 67(5):715–726. https://doi.org/10.1007/s00018-009-0186-0
Farrelly-Rosch A, Lau CL, Patil N et al (2017) Combination of valproic acid and morpholino splice-switching oligonucleotide produces improved outcomes in spinal muscular atrophy patient-derived fibroblasts. Neurochem Int 108:213–221. https://doi.org/10.1016/j.neuint.2017.02.016
Ulrich S, Boturyn D, Marra A et al (2014) Oxime ligation: a chemoselective click-type reaction for accessing multifunctional biomolecular constructs. Chemistry 20(1):34–41. https://doi.org/10.1002/chem.201302426
Agard NJ, Prescher JA, Bertozzi CR (2004) A strain-promoted [3+2] azide-alkyne cycloaddition for covalent modification of biomolecules in living systems. J Am Chem Soc 126(46):15046–15047. https://doi.org/10.1021/ja044996f
Blackman ML, Royzen M, Fox JM (2008) Tetrazine ligation: fast bioconjugation based on inverse-electron-demand Diels-Alder reactivity. J Am Chem Soc 130(41):13518–13519. https://doi.org/10.1021/ja8053805
Koniev O, Wagner A (2015) Developments and recent advancements in the field of endogenous amino acid selective bond forming reactions for bioconjugation. Chem Soc Rev 44(15):5495–5551. https://doi.org/10.1039/c5cs00048c
Tornøe CW, Christensen C, Meldal M (2002) Peptidotriazoles on solid phase: [1,2,3]-triazoles by regiospecific copper(i)-catalyzed 1,3-dipolar cycloadditions of terminal alkynes to azides. J Org Chem 67(9):3057–3064
Acknowledgment
This work was supported by MND Research Institute of Australia (MNDRIA GIA-1722), National Health and Medical Research Council (Project Grant 1104299), and the Stafford Fox Medical Research Foundation.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Karas, J., Turner, B.J., Shabanpoor, F. (2018). The Assembly of Fluorescently Labeled Peptide–Oligonucleotide Conjugates via Orthogonal Ligation Strategies. In: Yokota, T., Maruyama, R. (eds) Exon Skipping and Inclusion Therapies. Methods in Molecular Biology, vol 1828. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-8651-4_22
Download citation
DOI: https://doi.org/10.1007/978-1-4939-8651-4_22
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-8650-7
Online ISBN: 978-1-4939-8651-4
eBook Packages: Springer Protocols